Disparity between angiographic regression and clinical event rates with hydrophobic statins

被引：52

作者：

Ichihara, K ^{[1
]}

Satoh, K ^{[1
]}

机构：

[1] Hokkaido Coll Pharm, Dept Pharmacol, Otaru, Hokkaido 0470264, Japan

来源：

LANCET | 2002年 / 359卷 / 9324期

关键词：

D O I：

10.1016/S0140-6736(02)09098-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2195 / 2198

页数：4

共 25 条

[1] 4-HYDROXYBENZOATE - POLYPRENYL TRANSFERASE AND PRENYLATION OF 4-AMINOBENZOATE IN MAMMALIAN-TISSUES [J].

ALAM, SS ;

NAMBUDIRI, AMD ;

RUDNEY, H .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1975, 171 (01) :183-190

[2] Beneficial effects of Pravastatin (±colestyramine/niacin) initiated immediately after a coronary event (the randomized lipid-coronary artery disease [L-CAD] study) [J].

Arntz, HR ;

Agrawal, R ;

Wunderlich, W ;

Schnitzer, L ;

Stern, R ;

Fischer, F ;

Schultheiss, HP .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (12) :1293-1298

[3] CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].

BLANKENHORN, DH ;

AZEN, SP ;

KRAMSCH, DM ;

MACK, WJ ;

CASHINHEMPHILL, L ;

HODIS, HN ;

DEBOER, LWV ;

MAHRER, PR ;

MASTELLER, MJ ;

VAILAS, LI ;

ALAUPOVIC, P ;

HIRSCH, LJ .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :969-976

[4] PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II) [J].

CROUSE, JR ;

BYINGTON, RP ;

BOND, MG ;

ESPELAND, MA ;

CRAVEN, TE ;

SPRINKLE, JW ;

MCGOVERN, ME ;

FURBERG, CD .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (07) :455-459

[5] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[6] INVITRO AND INVIVO SYNTHESIS OF DOLICHOL AND OTHER MAIN MEVALONATE PRODUCTS IN VARIOUS ORGANS OF THE RAT [J].

ELMBERGER, PG ;

KALEN, A ;

APPELKVIST, EL ;

DALLNER, G .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 168 (01) :1-11

[7] REGULATION OF THE MEVALONATE PATHWAY [J].

GOLDSTEIN, JL ;

BROWN, MS .

NATURE, 1990, 343 (6257) :425-430

[8] Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (lipoprotein and coronary atherosclerosis study [LCAS]) [J].

Herd, JA ;

Ballantyne, CM ;

Farmer, JA ;

Ferguson, JJ ;

Jones, PH ;

West, S ;

Gould, KL ;

Gotto, AM .

AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (03) :278-286

[9] INFLUENCES OF PRAVASTATIN AND SIMVASTATIN, HMG-COA REDUCTASE INHIBITORS, ON MYOCARDIAL STUNNING IN DOGS [J].

ICHIHARA, K ;

SATOH, K ;

ABIKO, Y .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (06) :852-856

[10] EFFECTS OF LIPID-LOWERING BY PRAVASTATIN ON PROGRESSION AND REGRESSION OF CORONARY-ARTERY DISEASE IN SYMPTOMATIC MEN WITH NORMAL TO MODERATELY ELEVATED SERUM-CHOLESTEROL LEVELS - THE REGRESSION GROWTH EVALUATION STATIN STUDY (REGRESS) [J].

JUKEMA, JW ;

BRUSCHKE, AVG ;

VANBOVEN, AJ ;

REIBER, JHC ;

BAL, ET ;

ZWINDERMAN, AH ;

JANSEN, H ;

BOERMA, GJM ;

VANRAPPARD, FM ;

LIE, KI .

CIRCULATION, 1995, 91 (10) :2528-2540

← 1 2 3 →